Quinlog, Raycel A.

HRN: 21-45-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
CEFUROXIME 750MG (VIAL)
06/10/2022
06/16/2022
IV
750mg
Q8h
Uti; Molar Pregnancy
Waiting Final Action 
06/13/2022
CEFTRIAXONE 1G (VIAL)
06/13/2022
06/20/2022
IV
2grams
OD
UTI; Molar Pregnancy
Waiting Final Action 
06/25/2022
CEFUROXIME 500MG (TAB)
06/25/2022
07/02/2022
PO
500mg
Q12
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: